17022-31-0 Usage
Description
ETHYL 2-PROPYLPENTANOATE, also known as Valproic Acid Ethyl Ester, is the ethyl ester derivative of one of the major antiepileptic drugs, Valproic Acid. It is characterized by its pleasant odor and marked resistance to clouding and crystallization.
Uses
Used in Biofuel Industry:
ETHYL 2-PROPYLPENTANOATE is used as a potential biofuel due to its properties that make it suitable for use as an alternative energy source.
Used in Fragrance Industry:
ETHYL 2-PROPYLPENTANOATE is used as a fragrance ingredient for its pleasant odor, making it suitable for use in various scented products.
Used in Pharmaceutical Industry:
ETHYL 2-PROPYLPENTANOATE is used as an intermediate in the synthesis of antiepileptic drugs, specifically Valproic Acid, which is used for the treatment of various neurological disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 17022-31-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,0,2 and 2 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 17022-31:
(7*1)+(6*7)+(5*0)+(4*2)+(3*2)+(2*3)+(1*1)=70
70 % 10 = 0
So 17022-31-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H20O2/c1-4-7-9(8-5-2)10(11)12-6-3/h9H,4-8H2,1-3H3
17022-31-0Relevant articles and documents
Enantio- and Regioselective Palladium(II)-Catalyzed Dioxygenation of (Aza-)Alkenols
Giofrè, Sabrina,Molteni, Letizia,Nava, Donatella,Lo Presti, Leonardo,Beccalli, Egle Maria
supporting information, p. 21723 - 21727 (2021/09/08)
An oxidative Pd-catalyzed intra-intermolecular dioxygenation of (aza-)alkenols has been reported, with total regioselectivity. To study the stereoselectivity, different chiral ligands as well as different hypervalent-iodine compounds have been compared. I
COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
-
Paragraph 0106; 0107, (2016/07/05)
The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for treating or preventing neurological disorders may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of epilepsy, bipolar disorder, migraine, schizophrenia, depression, Alzheimer's disease, cancer, HIV and familial adenomatous polyposis.
